| 000 | 01618 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517195523.0 | ||
| 264 | 0 | _c20181001 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1466-609X | ||
| 024 | 7 |
_a10.1186/s13054-018-1943-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuo, Qiongzhen | |
| 245 | 0 | 0 |
_aSerum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study. _h[electronic resource] |
| 260 |
_bCritical care (London, England) _c01 2018 |
||
| 300 |
_a15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 |
_aCommunity-Acquired Infections _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPneumonia _xclassification |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptors, Urokinase Plasminogen Activator _xanalysis |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aSyndecan-4 _xanalysis |
| 700 | 1 | _aNing, Pu | |
| 700 | 1 | _aZheng, Yali | |
| 700 | 1 | _aShang, Ying | |
| 700 | 1 | _aZhou, Bing | |
| 700 | 1 | _aGao, Zhancheng | |
| 773 | 0 |
_tCritical care (London, England) _gvol. 22 _gno. 1 _gp. 15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13054-018-1943-y _zAvailable from publisher's website |
| 999 |
_c28012880 _d28012880 |
||